Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480904 · ClinicalTrials.gov registry record
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
A clinical trial of Solid Tumor and ALL, Adult, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT05480904: Recruiting study of Solid Tumor and ALL, Adult, sponsored by St. Jude Children's Research Hospital.
NCT05480904 is a study of Solid Tumor and ALL, Adult that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 120 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05480904, a study of Solid Tumor and ALL, Adult, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objective The primary aim of this protocol is to estimate the prevalence of various sleep disorders among long-term survivors of childhood ALL, CNS tumors, and non- CNS solid tumors. Exploratory Objective The exploratory objective of the study is to explore associations between the prevalence of sleep disorders and clinical outcomes collected in SJLIFE.
Primary Outcome
ISI is a seven-item questionnaire that looks at symptoms of clinical insomnia. The ISI assesses insomnia symptoms over the past 14 days and has demonstrated good reliability and validity. The total ISI score ranges from 0 to 28, with scores \< 8 indicating no significant insomnia.
Conditions Studied
Interventions
- OTHER Neurocognitive (Thinking) Testing
- DIAGNOSTIC_TEST CNS Vital Signs (Thinking) Testing
- OTHER Health Questionnaires, Sleep Surveys & Sleep Diary
- DIAGNOSTIC_TEST Echocardiography/EKG
- DIAGNOSTIC_TEST Pulmonary Function
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-04-17 |
| Est. Completion | 2027-01 |
What NCT05480904 shows while recruiting
NCT05480904 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (46% lower).
The record links to 3 conditions, with Solid Tumor appearing as the primary indexed condition, and to 5 interventions - of which Neurocognitive (Thinking) Testing is the first listed.
NCT05480904 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05480904 about?
NCT05480904 is a clinical study titled "Characterizing Sleep Among Long-term Survivors of Childhood Cancer". The patients are being asked to take part in this clinical trial because they received cancer treatment as a child at St. Jude. The study comprehensively examines sleep among three distinct diagnostic groups of survivors in the SJLIFE cohort: ALL, CNS tumors, and non-CNS solid tumors. Primary Objec...
What is the current status of trial NCT05480904?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-04-17. Estimated completion is 2027-01.
What conditions does trial NCT05480904 study?
This clinical trial studies the following conditions: Solid Tumor, ALL, Adult, CNS Tumor.
What interventions are being tested in trial NCT05480904?
The interventions under investigation include: Neurocognitive (Thinking) Testing (OTHER), CNS Vital Signs (Thinking) Testing (DIAGNOSTIC_TEST), Health Questionnaires, Sleep Surveys & Sleep Diary (OTHER), Echocardiography/EKG (DIAGNOSTIC_TEST), Pulmonary Function (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05480904?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05480904 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05480904's enrollment target sits among peer trials
120 72nd of 196 higher than 122 of 196 other Solid Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI